Clinical Trial Update: Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating the effect of Fostair on biomarkers of platelet adhesion in idiopathic pulmonary fibrosis (IPF).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Fostair

Snippet

Sponsor: Hull University Teaching Hospitals NHS Trust | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED